School of Science, Information Technology and Engineering, University of Ballarat, P.O. Box 663, Ballarat, Victoria 3353, Australia.
Artif Intell Med. 2013 Jul;58(3):185-93. doi: 10.1016/j.artmed.2013.04.007. Epub 2013 Jun 13.
This article addresses the problem of determining optimal sequences of tests for the clinical assessment of cardiac autonomic neuropathy (CAN). We investigate the accuracy of using only one of the recommended Ewing tests to classify CAN and the additional accuracy obtained by adding the remaining tests of the Ewing battery. This is important as not all five Ewing tests can always be applied in each situation in practice.
We used new and unique database of the diabetes screening research initiative project, which is more than ten times larger than the data set used by Ewing in his original investigation of CAN. We utilized decision trees and the optimal decision path finder (ODPF) procedure for identifying optimal sequences of tests.
We present experimental results on the accuracy of using each one of the recommended Ewing tests to classify CAN and the additional accuracy that can be achieved by adding the remaining tests of the Ewing battery. We found the best sequences of tests for cost-function equal to the number of tests. The accuracies achieved by the initial segments of the optimal sequences for 2, 3 and 4 categories of CAN are 80.80, 91.33, 93.97 and 94.14, and respectively, 79.86, 89.29, 91.16 and 91.76, and 78.90, 86.21, 88.15 and 88.93. They show significant improvement compared to the sequence considered previously in the literature and the mathematical expectations of the accuracies of a random sequence of tests. The complete outcomes obtained for all subsets of the Ewing features are required for determining optimal sequences of tests for any cost-function with the use of the ODPF procedure. We have also found two most significant additional features that can increase the accuracy when some of the Ewing attributes cannot be obtained.
The outcomes obtained can be used to determine the optimal sequences of tests for each individual cost-function by following the ODPF procedure. The results show that the best single Ewing test for diagnosing CAN is the deep breathing heart rate variation test. Optimal sequences found for the cost-function equal to the number of tests guarantee that the best accuracy is achieved after any number of tests and provide an improvement in comparison with the previous ordering of tests or a random sequence.
本文旨在探讨心脏自主神经病变(CAN)临床评估中测试序列优化的问题。我们研究了仅使用推荐的 Ewing 测试之一对 CAN 进行分类的准确性,以及通过添加 Ewing 电池的其余测试可以获得的额外准确性。这一点很重要,因为在实际应用中,并非所有五项 Ewing 测试都能始终适用于每种情况。
我们使用了糖尿病筛查研究计划的新的、独特的数据库,该数据库的规模是 Ewing 最初研究 CAN 时所用数据集的 10 倍以上。我们利用决策树和最优决策路径查找器(ODPF)程序来确定测试的最优序列。
我们介绍了使用推荐的每项 Ewing 测试对 CAN 进行分类的准确性,以及通过添加 Ewing 电池的其余测试可以获得的额外准确性。我们找到了成本函数等于测试数量的最佳测试序列。CAN 分为 2、3 和 4 类时,最优序列初始段的准确率分别为 80.80、91.33、93.97 和 94.14,而相应的 79.86、89.29、91.16 和 91.76,78.90、86.21、88.15 和 88.93,与文献中之前考虑的序列以及随机测试序列的准确率数学期望相比,均有显著提高。使用 ODPF 程序,对于 Ewing 特征的所有子集,都需要确定最优测试序列,以确定任何成本函数的最优测试序列。我们还发现了两个最显著的附加特征,在某些 Ewing 属性无法获得时,可以提高准确率。
通过遵循 ODPF 程序,可以为每个单独的成本函数确定最优测试序列。结果表明,用于诊断 CAN 的最佳单项 Ewing 测试是深呼吸心率变异测试。对于成本函数等于测试数量的最优序列保证了在进行任意数量的测试后可以达到最佳准确率,并与之前的测试顺序或随机序列相比有所提高。